Wenlin Du

1.4k total citations · 1 hit paper
36 papers, 1.1k citations indexed

About

Wenlin Du is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Wenlin Du has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Hematology. Recurrent topics in Wenlin Du's work include Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Ubiquitin and proteasome pathways (5 papers). Wenlin Du is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Glycosylation and Glycoproteins Research (5 papers) and Ubiquitin and proteasome pathways (5 papers). Wenlin Du collaborates with scholars based in Japan, China and United States. Wenlin Du's co-authors include Xiaozhou Mou, Jiayu Yao, Maohua Cai, Yuanyuan Zhao, Luo‐Qin Fu, Michiie Sakamoto, Taisuke Mori, Yohei Masugi, Taketo Yamada and Kathryn Effendi and has published in prestigious journals such as Blood, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Wenlin Du

32 papers receiving 1.1k citations

Hit Papers

The roles of tumor-associated macrophages in tumor angiog... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenlin Du Japan 19 554 320 258 195 124 36 1.1k
Jinbiao Chen Australia 20 622 1.1× 423 1.3× 384 1.5× 139 0.7× 142 1.1× 70 1.4k
Eric Sulpice France 18 674 1.2× 228 0.7× 163 0.6× 158 0.8× 56 0.5× 34 1.1k
Jinmei Yu China 15 616 1.1× 234 0.7× 190 0.7× 211 1.1× 209 1.7× 28 1.1k
Hui Zhou China 21 525 0.9× 371 1.2× 188 0.7× 230 1.2× 62 0.5× 104 1.3k
Jian Wu China 21 956 1.7× 474 1.5× 309 1.2× 255 1.3× 393 3.2× 91 1.7k
Chang Xian Li China 17 451 0.8× 300 0.9× 427 1.7× 266 1.4× 138 1.1× 29 1.2k
Josip S. Herman Germany 11 715 1.3× 165 0.5× 504 2.0× 202 1.0× 198 1.6× 13 1.4k
Niklas K. Finnberg United States 18 678 1.2× 434 1.4× 453 1.8× 234 1.2× 240 1.9× 40 1.4k

Countries citing papers authored by Wenlin Du

Since Specialization
Citations

This map shows the geographic impact of Wenlin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenlin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenlin Du more than expected).

Fields of papers citing papers by Wenlin Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenlin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenlin Du. The network helps show where Wenlin Du may publish in the future.

Co-authorship network of co-authors of Wenlin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Wenlin Du. A scholar is included among the top collaborators of Wenlin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenlin Du. Wenlin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Du, Wenlin, Jingyi Zhu, Xin Liu, et al.. (2024). In situ one step growth of amorphous tin oxide electron transport layer for high-performance perovskite solar cells. RSC Advances. 14(18). 12650–12657.
4.
Lan, Huanrong, et al.. (2021). Role of immune regulatory cells in breast cancer: Foe or friend?. International Immunopharmacology. 96. 107627–107627. 19 indexed citations
5.
Wu, Feifei, Li Zhou, W. Yang, et al.. (2016). Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells. Frontiers in Pharmacology. 7. 465–465. 34 indexed citations
6.
Matsushita, Maiko, Yuka Hasegawa, Noriko Tabata, et al.. (2015). A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts. PLoS ONE. 10(1). e0116135–e0116135. 9 indexed citations
7.
Tomita, Hirofumi, Ken Hoshino, Yasushi Fuchimoto, et al.. (2013). Acoustic radiation force impulse imaging for assessing graft fibrosis after pediatric living donor liver transplantation: A pilot study. Liver Transplantation. 19(11). 1202–1213. 29 indexed citations
8.
Yamada, Kohji, Hiroko Nishida, Wenlin Du, et al.. (2013). Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription. PLoS ONE. 8(4). e62304–e62304. 31 indexed citations
9.
Tabata, Noriko, Nobutaka Matsumura, Hideaki Takashima, et al.. (2012). A Phthalimide Derivative That Inhibits Centrosomal Clustering Is Effective on Multiple Myeloma. PLoS ONE. 7(6). e38878–e38878. 21 indexed citations
10.
Fujimura, Naoki, Hideaki Obara, Koichi Suda, et al.. (2012). Neutrophil elastase inhibitor improves survival rate after ischemia reperfusion injury caused by supravisceral aortic clamping in rats. Journal of Surgical Research. 180(1). e31–e36. 23 indexed citations
11.
Kawakami, Takao, Kathryn Effendi, Ken Yamazaki, et al.. (2011). Identification by Differential Tissue Proteome Analysis of Talin-1 as a Novel Molecular Marker of Progression of Hepatocellular Carcinoma. Oncology. 80(5-6). 406–415. 44 indexed citations
13.
Ono, Shigeshi, Hideaki Obara, Atsushi Takayanagi, et al.. (2011). Suppressive Effects of Interleukin-18 on Liver Function in Rat Liver Allografts. Journal of Surgical Research. 176(1). 293–300. 18 indexed citations
14.
Yamazaki, Ken, Yohei Masugi, Taisuke Mori, et al.. (2010). Reduced transforming growth factor-β receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Laboratory Investigation. 90(9). 1339–1345. 50 indexed citations
15.
Effendi, Kathryn, Taisuke Mori, Mina Komuta, et al.. (2009). Bmi‐1 gene is upregulated in early‐stage hepatocellular carcinoma and correlates with ATP‐binding cassette transporter B1 expression. Cancer Science. 101(3). 666–672. 45 indexed citations
16.
Yamazaki, Ken, Masaaki Takamura, Yohei Masugi, et al.. (2009). Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility. Laboratory Investigation. 89(4). 425–432. 60 indexed citations
17.
Du, Wenlin, Nobumichi Hozumi, Michiie Sakamoto, Jun-ichi Hata, & Taketo Yamada. (2008). Reconstitution of Schwannian Stroma in Neuroblastomas Using Human Bone Marrow Stromal Cells. American Journal Of Pathology. 173(4). 1153–1164. 10 indexed citations
18.
Nakata, Yuji, Kensuke Kondoh, Akinori Hashiguchi, et al.. (2007). Mutated D4-guanine diphosphate–dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion. Experimental Hematology. 36(1). 37–50. 5 indexed citations
19.
Du, Wenlin, Yutaka Hattori, Akinori Hashiguchi, et al.. (2004). Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment. Pathology International. 54(5). 285–294. 30 indexed citations
20.
Sato, Norihide, Yutaka Hattori, Wenlin Du, et al.. (2002). Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity. Japanese Journal of Cancer Research. 93(4). 459–466. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026